Welcome to our dedicated page for International Flavors&Fragranc SEC filings (Ticker: IFF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The International Flavors & Fragrances Inc. (IFF) SEC filings page on Stock Titan provides centralized access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. IFF, whose common stock trades on the New York Stock Exchange under the symbol IFF, submits periodic and current reports that describe its financial condition, segment performance, governance changes and material corporate actions.
Among the most important documents for investors are IFF’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which present audited or reviewed financial statements, detailed segment information for Taste, Health & Biosciences, Scent and Food Ingredients, and discussions of risk factors and management’s analysis. In addition, IFF frequently files current reports on Form 8-K to disclose specific events, such as quarterly and interim financial results, amendments to its bylaws, appointments or departures of directors and certain officers, authorization of share repurchase programs and other significant developments.
Users interested in governance and board structure can review 8-K filings that describe new director appointments, committee assignments and changes arising from cooperation agreements with shareholders. Filings also cover bylaw amendments, including updates to committee nomenclature and clarifications of indemnification rights under applicable law. Capital allocation decisions, such as the authorization of a share repurchase program, are likewise reported in 8-Ks, providing insight into how the board approaches the company’s capital structure.
Through Stock Titan, each new IFF filing is captured from EDGAR and paired with AI-powered summaries that explain the main points in accessible language. These summaries help readers quickly understand the implications of complex documents, whether they relate to segment performance, governance changes or other material events. Investors can use this page to track IFF’s 10-K and 10-Q reports, 8-K event disclosures and, where applicable, insider transaction reports on Form 4, all in one place with contextual AI insights.
International Flavors & Fragrances reported an insider equity transaction by its President, Food Ingredients, on 01/02/2026. The executive exercised and settled 1,825 restricted stock units (RSUs) into the same number of shares of common stock at an exercise price of $0, reflecting normal vesting of awards granted on January 2, 2025.
To cover taxes due at vesting, 633 shares were withheld at a price of $68.03 per share, leaving the executive with 1,192 shares of common stock owned directly after the transactions. Following this vesting event, the executive also continues to hold 11,400 RSUs, which represent a right to receive additional shares in the future under prior equity grants, including a grant of 5,476 RSUs scheduled to vest in three equal annual installments beginning on the first anniversary of the January 2, 2025 grant date.
International Flavors & Fragrances Inc. (IFF) executive vice president and general counsel reported buying company stock in the open market. On 12/12/2025, the officer acquired 3,100 shares of common stock at a price of $63.48 per share, coded as a purchase transaction. Following this transaction, the executive directly beneficially owns 15,100 shares of IFF common stock.
International Flavors & Fragrances Inc. (IFF) reported an equity transaction by its EVP, Global Operations Officer, on December 1, 2025. The officer converted 10,774 Restricted Stock Units (RSUs) into an equal number of shares of common stock at an exercise price of $0, reflecting the one-for-one RSU-to-share conversion.
To cover taxes due upon vesting, 5,214 shares were withheld at a price of $69.27 per share, reducing the directly held common stock to 14,859 shares after the transaction. Following this vesting, the officer still holds 11,752 RSUs as derivative securities. These RSUs stem from a buyout grant of 21,548 units awarded on December 1, 2022, vesting 25% in 2023, 25% in 2024, and 50% on December 1, 2025.
International Flavors & Fragrances (IFF) reported insider buying by a director. On 11/10/2025, the director acquired 20,000 shares of common stock at a weighted average price of $62.9609, with trades ranging from $62.65 to $63.43. On 11/11/2025, the director acquired an additional 13,000 shares at a weighted average price of $64.4423, with trades ranging from $63.19 to $65.31.
Following these transactions, the reporting person beneficially owned 33,000 shares, held directly.
International Flavors & Fragrances (IFF) filed a Form 4 reporting open‑market stock purchases by a director. On 11/06/2025, 1,500 shares were acquired at $62.905, bringing direct holdings to 9,196 shares. On 11/07/2025, 5,250 shares were acquired at a weighted average price of $62.4633 (purchases ranged from $62.25 to $62.62), increasing direct holdings to 14,446 shares. Also on 11/07/2025, 2,000 shares were acquired at $62.09, held indirectly by the director’s spouse, with 8,500 shares held indirectly after the transaction.
IFF filed a Form 144 notice for a proposed sale of 4,060 common shares. The filing lists an aggregate market value of $253,809.54, with an approximate sale date of 11/07/2025 on the NYSE through Fidelity Brokerage Services LLC. The seller’s shares were acquired via restricted stock vesting on multiple dates from 10/03/2023 through 11/01/2025. Shares outstanding were 256,096,379.
International Flavors & Fragrances (IFF) reported Q3 2025 results showing softer sales but positive net income. Net sales were $2,694 million versus $2,925 million a year ago, and net income attributable to shareholders was $40 million (diluted EPS $0.16) versus $58 million ($0.23). Adjusted Operating EBITDA was $519 million versus $568 million.
Year‑to‑date, IFF posted a net loss of $392 million driven by a $1,153 million goodwill impairment and a $108 million loss on assets held for sale, partially offset by a $488 million gain on extinguishment of debt. Cash from operations reached $532 million, aided by divestiture activity: the Pharma Solutions sale closed for $2,564 million cash (fair value consideration $2,651 million including a $100 million earnout estimate), the Nitrocellulose sale brought $161 million, and a Tobacco Flavoring business sale yielded $20 million.
The balance sheet strengthened: cash was $621 million and long‑term debt fell to $4,741 million from $7,564 million. IFF recorded a $108 million impairment for the Soy Crush, Concentrates & Lecithin business now held for sale, with closing expected by the second quarter of 2026. The Board also authorized a $500 million share repurchase program.
International Flavors & Fragrances (IFF) furnished a press release reporting financial results for the quarter ended September 30, 2025. The company will host a live webcast to discuss third quarter 2025 results on November 5, 2025 at 9:00 a.m. ET, with access via ir.iff.com. A recording will be posted about one hour after the event and remain available for one year. The press release was furnished as an exhibit and is not deemed filed under the Exchange Act.
International Flavors & Fragrances (IFF) reported an insider equity award on Form 4. A company Director acquired 1,712 Restricted Stock Units (RSUs) on 11/03/2025.
The RSUs convert to Common Stock on a one‑for‑one basis and carry an exercise price of $0.0000. According to the filing, these RSUs will vest on May 1, 2026. Following the transaction, 1,712 derivative securities are shown as beneficially owned with direct (D) ownership.
International Flavors & Fragrances (IFF) reported an insider equity change: a company director acquired 1,712 restricted stock units (RSUs) on 11/03/2025, as disclosed on Form 4. The filing lists the RSU transaction at $0.0000.
The RSUs convert to Common Stock on a one-for-one basis and are scheduled to vest on May 1, 2026. Following the reported transaction, the filing shows 1,712 derivative securities beneficially owned with direct ownership.